Foundation for Sarcoidosis Research (FSR) Announces $300,000 in Grant Funding to Improve Diagnosis and Treatment of Sarcoidosis
The FSR Pilot Grant program, initiated in 2018, seeks to fund innovative research in both clinical and basic science settings ...
Nasdaq20d
ATyr Pharma Advances Pulmonary Sarcoidosis Treatment With Efzofitimod At ATS 2025
(RTTNews) - aTyr Pharma, Inc. (ATYR), a clinical-stage biotechnology company ... of interstitial lung diseases or ILD such as pulmonary sarcoidosis. The posters will showcase data from the ...